Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | CTSD | P07339 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419083 | 1.00 | KMT2A (0.48) | KMT2AMEN1GAAALDH1A1LMNA | |
| SCHEMBL483297 | 1.00 | KMT2A (0.48) | KMT2AMEN1GAAALDH1A1LMNA | |
| SCHEMBL157178 | 1.00 | KMT2A (0.48) | KMT2AMEN1GAAALDH1A1LMNA | |
| SCHEMBL1612770 | 0.97 | KMT2A (0.49) | KMT2AMEN1GAAALDH1A1LMNA | |
| SCHEMBL2436455 | 0.93 | KMT2A (0.46) | KMT2AMEN1GAAALDH1A1LMNA | |
| SCHEMBL1402160 | 0.93 | LMNA (0.48) | KMT2AMEN1GAALMNASMN1; SMN2 | |
| SCHEMBL157766 | 0.93 | KMT2A (0.47) | KMT2AMEN1GAAALDH1A1LMNA | |
| SCHEMBL29408450 | 0.93 | KMT2A (0.47) | KMT2AMEN1GAAALDH1A1LMNA | |
| SCHEMBL7689446 | 0.92 | SMN1; SMN2 (0.46) | KMT2AALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL7099648 | 0.92 | MEN1 (0.49) | KMT2AMEN1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3488700-B1 | COMPOSITION COMPRISING A BIOLOGICAL CONTROL AGENT AND A FUNGICIDE | BAYER CROPSCIENCE AG (DE) | 2020-12-16 | — | — | EP | claimed |
| EP-2854545-B1 | COMPOSITIONS COMPRISING A BIOLOGICAL CONTROL AGENT AND AN INSECTICIDE | BAYER CROPSCIENCE AG (DE) | 2020-10-21 | — | — | EP | claimed |
| EP-3010893-B1 | ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AG (DE) | 2019-10-02 | — | — | EP | claimed |
| US-20190159451-A1 | ACTIVE COMPOUND COMBINATIONS AND METHODS TO PROTECT THE PROPAGATION MATERIAL OF PLANTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-05-30 | — | — | US | claimed |
| EP-3488700-A1 | COMPOSITION COMPRISING A BIOLOGICAL CONTROL AGENT AND A FUNGICIDE | Bayer CropScience Aktiengesellschaft (DE) | 2019-05-29 | — | — | EP | claimed |
| EP-2854552-B1 | COMPOSITION COMPRISING A BIOLOGICAL CONTROL AGENT AND A FUNGICIDE SELECTED FROM INHIBITORS OF AMINO ACID OR PROTEIN BIOSYNTHESIS, INHIBITORS OF ATP PRODUCTION AND INHIBITORS OF THE CELL WALL SYNTHESIS | BAYER CROPSCIENCE AG (DE) | 2019-05-08 | — | — | EP | claimed |
| EP-3409120-A1 | COMPOSITION COMPRISING A BIOLOGICAL CONTROL AGENT AND A FUNGICIDE | Bayer CropScience Aktiengesellschaft (DE) | 2018-12-05 | — | — | EP | claimed |
| EP-3010889-B1 | ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AG (DE) | 2018-10-03 | — | — | EP | claimed |
| EP-2879493-B1 | PESTICIDAL COMPOSITIONS COMPRISING A TERPENE MIXTURE AND FLUPYRADIFURONE | BAYER CROPSCIENCE AG (DE) | 2018-09-19 | — | — | EP | claimed |
| EP-2854547-B1 | COMPOSITION COMPRISING A BIOLOGICAL CONTROL AGENT AND TRIFLOXYSTROBIN | BAYER CROPSCIENCE AG (DE) | 2018-08-01 | — | — | EP | claimed |
| EP-1570736-A1 | Fungicide composition comprising an arylamidine derivative and known fungicide compounds | Bayer CropScience S.A. (FR) | 2005-09-07 | — | — | EP | claimed |
| EP-1444197-B1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2005-03-30 | — | — | EP | claimed |
| US-20050026785-A1 | Novel phenyl-propargylether derivatives | SYNGENTA CROP PROTECTION, INC. | 2005-02-03 | — | — | US | claimed |
| EP-1444197-A1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | Syngenta Participations AG (CH) | 2004-08-11 | — | — | EP | claimed |
| EP-1282595-B1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-07-14 | — | — | EP | claimed |
| WO-2003041728-A9 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-04-22 | — | — | WO | claimed |
| US-6683211-B1 | FUNGICIDES FOR CROPS | SYNGENTA CROP PROTECTION, INC. | 2004-01-27 | — | — | US | claimed |
| WO-2003041728-A1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2003-05-22 | — | — | WO | claimed |
| EP-1282595-A1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | Syngenta Participations AG (CH) | 2003-02-12 | — | — | EP | claimed |
| WO-2001087822-A1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2001-11-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190159451-A1 | ACTIVE COMPOUND COMBINATIONS AND METHODS TO PROTECT THE PROPAGATION MATERIAL OF PLANTS | BROX, CAT, MPG | KMT2A 3113/4885MEN1 1143/4885GAA 811/4885 |
| US-20050026785-A1 | Novel phenyl-propargylether derivatives | OR10J3, PRXL2A, OSR1 | KMT2A 2350/4885MEN1 1557/4885GAA 3350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.